News
Tonix Pharmaceuticals Holding shares have surged 62% since my Buy call, driven by optimism for Tonmya’s FDA decision. Click ...
1d
TipRanks on MSNInsmed Gains FDA Approval for BRINSUPRI
Insmed ( ($INSM) ) just unveiled an update. On August 12, 2025, Insmed announced that the FDA approved BRINSUPRI, the first and only treatment for ...
On Monday, the U.S. Food and Drug Administration (FDA) approved Amphastar Pharmaceuticals, Inc.’s (NASDAQ:AMPH) Abbreviated ...
Detailed price information for Milestone Pharmaceuticals Inc (MIST-Q) from The Globe and Mail including charting and trades.
Sarepta Therapeutics said Friday that the deaths of two patients taking its marketed gene therapy Elevidys® (delandistrogene ...
Teal Health ®, a virtual women's health company on a mission to eliminate cervical cancer, today announced the general ...
11h
TipRanks on MSNKamada Ltd. Reports Strong Financial Results and FDA Approval in August 2025
Kamada ( ($IL:KMDA) ) just unveiled an update. Kamada Ltd. reported strong financial results for the second quarter and first half of 2025, with ...
Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal ...
Aurinia Pharmaceuticals Inc. achieved record Lupkynis sales of $66.6M in Q2 while managing cash flow. Click for insights on ...
Shares of Tonix Pharmaceuticals are trading sharply higher Tuesday morning. The stock is gaining following the release of the ...
2d
Stockhead on MSNHealth Check: Syntara shares plunge on FDA ‘do more trial homework’ edict
The US Food and Drug Administration has 'suggested' to Syntara that it should carry out an additional myelofibrosis study with a control arm.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results